TOP OF THE NEWS
California cracks down on DTC testing
Monogram enters oncology market
BUSINESS NEWS
Invitrogen to merge with Applied Biosystems
J&J acquires Swedish IVD company
Dako, Bristol-Meyers partner on companion diagnostics
Rosetta Genomics buys Pennsylvania lab
SCIENCE/TECHNOLOGY
BD’s C. difficile test gets CE Mark
Biomarker-based test predicts prostate cancer recurrence
Elevated liver protein linked to diabetes risk
Urinary albumin tied to hypertension
Boston researchers get grant for breast cancer biomarker discovery
INSIDE DIAGNOSTICS INDUSTRY
DTC genetic testing under state scrutiny
REGULATORY NEWS
FDA sends manufacturers ASR ‘reminder’ letters
CMS adds new waived tests to fee schedule
FINANCIAL NEWS
IVD stocks down 9%
G-2 INSIDER
See you at Lab Institute!

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

August 2008 - Table of Contents

DTTR August 2008 (full PDF issue)

California Cracks Down on DTC Genetic Testing

Monogram Launches Breast Cancer Assay

Invitrogen, Applied Biosystems to Combine in $6.7B Deal

BD’s C. difficile Molecular Test Gets CE Mark

J&J Acquires Swedish IVD Company

DTC Genetic Testing Under Greater Scrutiny

FDA Sends ASR ‘Reminder’ Letters to IVD Manufacturers

Dako Partners With Bristol-Myers Squibb for Companion Diagnostics

Rosetta Genomics Buys Parkway Clinical Labs for $3m+

New Biomarker-Based Test Predicts Prostate Cancer Recurrence

Elevated Fetuin-A Levels Associated With Increased Diabetes Risk

Urinary Albumin Levels Can Predict Hypertension

Boston Researchers Awarded Grant for Breast Cancer Biomarkers

CMS Adds More Waived Tests to Lab Fee Schedule

IVD Stocks Fall 9%; Third Wave Rises on Takeover News

See You at Lab Institute!